Võrdle meetodeid

	DEXA	Kvantitatiivne suskeptibiliteetikaartimine
Valdkond	Meditsiiniline piltdiagnostika	Meditsiiniline piltdiagnostika
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	1987	2015
Looja	Harold Wahner	Yong Wang
Tüüp	X-ray-based bone density measurement	Quantitative MRI contrast mechanism
Algallikas	Kanis, J. A. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Report Series, 843, 1-129.	Wang, Y., Liu, T. (2015). Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magnetic Resonance in Medicine, 73(1), 82-101.
Rööpnimetused	Dual X-ray absorptiometry, DXA, bone densitometry	QSM, susceptibility-weighted imaging
Seotud	5	5
Kokkuvõte	Dual-Energy X-ray Absorptiometry (DEXA or DXA) is a non-invasive imaging technique that quantifies bone mineral density (BMD) by measuring the attenuation of X-rays at two different energies as they pass through bone and soft tissue. First developed by Wahner and colleagues in 1987, DEXA has become the gold standard for osteoporosis screening and fracture risk assessment. It is recommended by the World Health Organization for diagnosing osteoporosis and monitoring treatment response.	Quantitative Susceptibility Mapping (QSM) is a post-processing technique that converts MRI phase data into quantitative susceptibility values, enabling direct visualization and measurement of tissue magnetic properties. Developed by Wang, Liu, and colleagues, QSM transforms phase shifts caused by differences in magnetic susceptibility between tissues into tissue-specific biomarkers. It has revolutionized the sensitivity of MRI to iron, calcium, and other paramagnetic and diamagnetic substances, making it valuable in neurodegenerative disease diagnosis and tissue characterization.